Repositioning of Angiotensin II Receptor Blockers for Alzheimer’s Disease: An In-Silico Study

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Role of angiotensin receptor blockers in the context of Alzheimer's disease2023 · 16 citations
2. 2AT2R’s (Angiotensin II Type 2 Receptor’s) Role in Cognitive and Cerebrovascular Deficits in a Mouse Model of Alzheimer Disease2020 · 31 citations
3. 3Angiotensin II AT1 receptor blockers as treatments for inflammatory brain disorders2012 · 224 citations
4. 4Angiotensin IV Receptors Mediate the Cognitive and Cerebrovascular Benefits of Losartan in a Mouse Model of Alzheimer's Disease2017 · 81 citations
5. 5Decoding the Neuroprotective Intervention of Angiotensin Receptor Blockers: A Multimodal Approach Using <i>In Silico</i> Network Pharmacology, Molecular Modeling, and <i>In Vivo</i> Validation of Key Markers2025